Author: Piers Townley

Kielan Arblaster, our Policy & Public Affairs Assistant, reports from day three at the 2018 Labour Party annual conference

Monday marked the Policy team speaking and engaging with MPs and delegates for the second day of the 2018 Labour Party annual conference. Kielan Arblaster reports

Kielan Arblaster, our Policy & Public Affairs Assistant, reports from the conference

Tocagen, a clinical-stage, cancer-selective gene therapy company, recently announced that it has completed patient enrolment approximately three months ahead of schedule for their Toca 5 Phase 3 clinical trial

At last night’s charity awards ceremony, we were crowned Charity of the Year 2018

We are delighted to announce the appointment of Jack Morris CBE as our new chair of trustees

Our powerful campaign, Leave Nothing Unsaid. Leave Nothing Undone, uses supporters’ stories to support and inspire others

Cameron Miller, Head of Policy & Public Affairs highlights our recommendations for the NHS long term plan

Cameron Miller, Head of Policy & Public Affairs, reports from the day’s proceedings

A team of researchers have identified a new therapeutic target in glioblastoma cells that could halt the aggressive growth of this tumour type

The milestone galvanises the drive for support and research into brain tumours

Today sees the launch of the Less Survivable Cancer Taskforce’s campaign to double five-year survival for each of the six less survivable cancers

Laboratory experiments show that a synthetic chemical is able to shut off glioblastoma cells’ energy source, leading to cell death

On Tuesday night, MPs in Westminster adopted an amendment to the Trade Bill which indicates support for the United Kingdom remaining in the regulatory framework of the European Medicines Agency (EMA)

These guidelines, published today, have been updated for the first time in over a decade

Researchers from the Institute of Cancer Research discovered that tumour cells in paediatric high-grade gliomas work together to invade other structures of the brain

Today marks the 70th birthday of the National Health Service and The Brain Tumour Charity would like to celebrate all that it has done for our community

Results from a phase 1 clinical trial show that patients with recurrent glioblastoma treated with an inactive version of the polio virus live longer than those receiving standard treatment

New data presented at the recent American Association of Clinical Oncology (ASCO) meeting in Chicago by Abbvie, a pharmaceutical company, provides hope for those diagnosed with a glioblastoma

Helena Brown, our Policy & Public Affairs Assistant, outlines the current postcode disparity in patient experience

Last week, Billy Caldwell, a severely epileptic twelve year old boy, had his cannabis oil confiscated at Heathrow airport

Keilan Arblaster, our Policy Involvement Assistant, outlines the implications of this bill for our community

A study led by researchers from Duke Cancer Institute identifies genetic markers to classify previously undetermined glioblastomas

Kielan Arblastar, our Policy & Affairs Assistant, discusses the implications of the US Government’s Right to Try bill